Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English | Polski

Prolib Integro - strona głównaBiblioteka WSB we Wrocławiu

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Brandes, Vanessa"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Podgląd okładki
    Tytuł :
    Monitoring treatment response to Erlotinib in EGFR-mutated nonesmall-cell lung cancer brain metastases using serial O-(2-[18F]fluoroethyl)-L-tyrosine PET
    Autorzy :
    Abdulla, Diana S.Y.
    Scheffler, Matthias
    Brandes, Vanessa
    Ruge, Maximilian
    Kunze, Sabine
    Merkelbach-Bruse, Sabine
    Nogova, Lucia
    Michels, Sebastian
    Fischer, Rieke
    Riedel, Richard
    Büttner, Reinhard
    Persigehl, Thorsten
    Grau, Stefan
    Galldiks, Norbert
    Drzezga, Alexander
    Kobe, Carsten
    Wolf, Jürgen
    Pokaż więcej
    Temat :
    ddc:610
    Cancer Research
    Pulmonary and Respiratory Medicine
    Oncology
    18F-fluoroethyl-L-tyrosine
    Cancer research
    Lung cancer
    medicine.disease
    medicine
    Treatment response
    Non small cell
    Carcinoma
    business.industry
    business
    Erlotinib
    medicine.drug
    Egfr mutation
    Positron emission tomography
    medicine.diagnostic_test
    Źródło :
    Clinical lung cancer 20(2), e148-e151 (2019). doi:10.1016/j.cllc.2018.10.011
    Dostęp URL :
    https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930a73291c28f530d559486870069c65
    https://juser.fz-juelich.de/record/859034
    Szczegóły
    Podgląd okładki
    Tytuł :
    P2.03b-028 Improved Overall Survival Following Implementation of NGS in Routine Diagnostics of Advanced Lung Cancer in Germany: Results of the NGM: Topic: Biomarkers
    Autorzy :
    Kostenko, Anna
    Pokaż więcej
    Źródło :
    In Journal of Thoracic Oncology January 2017 12(1) Supplement:S950-S951
    Czasopismo naukowe
    Szczegóły
    Podgląd okładki
    Tytuł :
    Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol.
    Autorzy :
    Scholten N; University of Cologne, Faculty of Human Sciences & Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science, Cologne, Germany.
    Leisse C; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany .
    Brandes V; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
    Oberröhrmann C; University of Cologne, Faculty of Human Sciences & Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science, Cologne, Germany.
    Ihle P; PMV research group at the Department of Psychiatry and Psychotherapy for Children and Young Adults, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
    Peter S; University of Cologne, Faculty of Human Sciences & Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science, Cologne, Germany.
    Hagemeier A; Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty, University of Cologne, Cologne, Germany.
    Hellmich M; Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty, University of Cologne, Cologne, Germany.
    Lindemann CH; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
    Samel C; Institute of Medical Statistics and Computational Biology (IMSB), Medical Faculty, University of Cologne, Cologne, Germany.
    Pfaff H; University of Cologne, Faculty of Human Sciences & Faculty of Medicine and University Hospital Cologne, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science, Cologne, Germany.
    Lehmann C; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
    Pokaż więcej
    Źródło :
    BMJ open [BMJ Open] 2022 Nov 14; Vol. 12 (11), pp. e061417. Date of Electronic Publication: 2022 Nov 14.
    Typ publikacji :
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms :
    Outpatients*
    Anti-Infective Agents*/therapeutic use
    Humans ; Prospective Studies ; Anti-Bacterial Agents/therapeutic use ; Ambulatory Care/methods ; Germany ; Observational Studies as Topic
    Czasopismo naukowe
    Szczegóły
    Podgląd okładki
    Tytuł :
    Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[ F]fluoroethyl)-L-tyrosine PET.
    Autorzy :
    Abdulla DSY; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Scheffler M; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Brandes V; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Ruge M; Center for Integrated Oncology Köln, Bonn, Germany; Department of Stereotaxy and Functional Neurosurgery, University Hospital of Cologne, Cologne, Germany.
    Kunze S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany.
    Merkelbach-Bruse S; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany.
    Nogova L; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Michels S; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Fischer R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Riedel R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
    Büttner R; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany.
    Persigehl T; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiology, University Hospital of Cologne, Cologne, Germany.
    Grau S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany.
    Galldiks N; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurology, University Hospital of Cologne, Cologne, Germany; Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany.
    Drzezga A; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
    Kobe C; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
    Wolf J; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany. Electronic address: .
    Pokaż więcej
    Źródło :
    Clinical lung cancer [Clin Lung Cancer] 2019 Mar; Vol. 20 (2), pp. e148-e151. Date of Electronic Publication: 2018 Nov 05.
    Typ publikacji :
    Case Reports; Journal Article
    MeSH Terms :
    Antineoplastic Agents/*therapeutic use
    Brain Neoplasms/*diagnosis
    Carcinoma, Non-Small-Cell Lung/*diagnosis
    Erlotinib Hydrochloride/*therapeutic use
    Lung Neoplasms/*diagnosis
    Tyrosine/*analogs & derivatives
    Adult ; Brain Neoplasms/drug therapy ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/secondary ; ErbB Receptors/genetics ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Mutation/genetics ; Positron-Emission Tomography
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies